Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) has entered into an exclusive licensing agreement with Allergan plc’s (NYSE: AGN) wholly owned subsidiary ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Management Comments

Piper Jaffray Remains Sidelined on Teva Pharma (TEVA) Following 1Q - PT to $58 May 10, 2016 8:04 AM Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled SyringeMay 10, 2016 6:45 AM